| 前收市價 | 6.96 |
| 開市 | 6.96 |
| 買盤 | 0.00 |
| 賣出價 | 0.00 |
| 拍板 | 136.00 |
| 到期日 | 2024-06-28 |
| 今日波幅 | 6.96 - 6.96 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
鉅亨網減肥筆市場未來十年達1000億美元 諾和諾德、禮來兩家瓜分
諸如諾和諾德 (NVO-US) 出品的 Wegovy 和禮來公司 (LLY-US) 生產的 Zepbound 這類減肥藥開拓了一個市場，分析師預計該市場將在 10 年內成長到 1000 億美元。
ZacksNovo Nordisk (NVO) Gains As Market Dips: What You Should Know
In the most recent trading session, Novo Nordisk (NVO) closed at $140.99, indicating a +0.13% shift from the previous trading day.
Barrons.comObesity-Drug Developers Look at What’s Next for a $100 Billion Market
Oppenheimer analyst Jay Olson spent several days last week listening as companies such as Eli Lilly discussed how to improve on blockbusters like Zepbound and Novo Nordisk’s Wegovy.
